Teza Capital Management’s Novartis NVS Stock Holding History

Teza Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,421	Closed	-$1.09M	–	254
2017 Q1	$1.09M	Buy	16,421 +13,277	+422%	+$885K	0.32%	89
2016 Q4	$205K	Buy	+3,144	New	+$204K	0.29%	167

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Teza Capital Management's NVS Position: Q2 2017 in Review

Teza Capital Management sold out of Novartis (NVS) in Q2 2017, closing a stake of 16,421 shares — an estimated $1.09M sold.

Teza Capital Management first reported a position in NVS in Q4 2016 and held it in 2 quarters. The position peaked at $1.09M in Q1 2017. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Teza Capital Management reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
Teza Capital Management sold 16,421 Novartis shares in Q2 2017, an estimated $1.09M.
Teza Capital Management first reported a position in Novartis in Q4 2016 and held it in 2 quarters.
Teza Capital Management's Novartis position peaked at $1.09M in Q1 2017.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Teza Capital Management's 13F filing for Q2 2017.